Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes

被引:46
作者
Diomede, L [1 ]
Sozzani, S [1 ]
Luini, W [1 ]
Algeri, M [1 ]
DeGioia, L [1 ]
Chiesa, R [1 ]
Lievens, PMJ [1 ]
Bugiani, O [1 ]
Forloni, G [1 ]
Tagliavini, F [1 ]
Salmona, M [1 ]
机构
[1] IST NEUROCHIRURG C BESTA,I-20133 MILAN,ITALY
关键词
D O I
10.1042/bj3200563
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion-related encephalopathies are characterized by the intracerebral accumulation of an abnormal isoform of the cellular prion protein (PrPc) named scrapie prion protein (PrPSc). The pathological forms of this protein and its cellular precursor are not only expressed in the brain but also, at lower concentrations, in peripheral tissues. We recently showed that a synthetic peptide corresponding to residues 106-126 [PrP-(106-126)] of the human PrP is toxic to neurons and trophic to astrocytes in vitro. Our experiments were aimed at verifying whether PrP-(106-126) and other peptides corresponding to fragments of the amyloid protein purified from brains of patients with Gerstmann-Straussler-Scheinker disease-namely PrP-(89-106), PrP-(106-114), PrP(127-147)- were capable of stimulating circulating leucocytes. Native PrP expression in human lymphocytes, monocytes and neutrophils was first confirmed using PCR amplification of total RNA, after reverse transcription, and immunoblot analysis of cell extracts with anti-PrP antibodies. PrP-(106-126), but not the other peptides, increased membrane microviscosity, intracellular Ca2+ concentration and cell migration in circulating leucocytes, and O-2(-*) production in monocytes and neutrophils. Membrane microviscosity was determined by the fluorescence polarization technique, using diphenylhexatriene as a probe, 300 s after the addition of PrP-(106-126) to the cell suspension in the concentration range 5-50 mu M. The increase in intracellular Ca2+ elicited by PrP-(106-126) was dose-dependent in the range 5-500 mu M. PrP-(106-126) stimulated O-2(-*) production in monocytes and neutrophils in a dose- (10-300 mu M) and time (5-30 min) dependent manner in the presence of 10 mu M dihydrocytochalasin B. Both the increase in Ca2+ concentration and the O-2(-*) production were partially sensitive to pertussis toxin. PrP-(106-126) stimulated leucocyte migration in a dose-dependent (30-300 mu M) manner and, at the highest concentration used, this migration was comparable with that elicited by 2.5 nM interleukin 8 or 10 nM fMet-Leu-Phe peptide.
引用
收藏
页码:563 / 570
页数:8
相关论文
共 36 条
  • [1] ALLAVENA P, 1994, BLOOD, V84, P2261
  • [2] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P99
  • [4] IDENTIFICATION OF A PROTEIN THAT PURIFIES WITH THE SCRAPIE PRION
    BOLTON, DC
    MCKINLEY, MP
    PRUSINER, SB
    [J]. SCIENCE, 1982, 218 (4579) : 1309 - 1311
  • [5] MOUSE CORTICAL-CELLS LACKING CELLULAR PRP SURVIVE IN CULTURE WITH A NEUROTOXIC PRP FRAGMENT
    BROWN, DR
    HERMS, J
    KRETZSCHMAR, HA
    [J]. NEUROREPORT, 1994, 5 (16) : 2057 - 2060
  • [6] A PRION PROTEIN-FRAGMENT MODIFIES PLASMA-MEMBRANE VISCOSITY AND INTRACELLULAR CALCIUM LEVEL
    BUGIANI, O
    DIOMEDE, L
    ALGERI, M
    DEGIOIA, L
    FLORIO, T
    SCHETTINI, G
    TAGLIAVINI, F
    FORLONI, G
    SALMONA, M
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (03) : 449 - 449
  • [7] CELLULAR ISOFORM OF THE SCRAPIE AGENT PROTEIN PARTICIPATES IN LYMPHOCYTE-ACTIVATION
    CASHMAN, NR
    LOERTSCHER, R
    NALBANTOGLU, J
    SHAW, I
    KASCSAK, RJ
    BOLTON, DC
    BENDHEIM, PE
    [J]. CELL, 1990, 61 (01) : 185 - 192
  • [8] TRANSMISSION AND SCANNING ELECTRON-MICROSCOPY OF SPONGIFORM CHANGE IN CREUTZFELDT-JAKOB DISEASE
    CHOU, SM
    PAYNE, WN
    GIBBS, CJ
    GAJDUSEK, DC
    [J]. BRAIN, 1980, 103 (DEC) : 885 - 904
  • [9] CHANGES IN THE LOCALIZATION OF BRAIN PRION PROTEINS DURING SCRAPIE INFECTION
    DEARMOND, SJ
    MOBLEY, WC
    DEMOTT, DL
    BARRY, RA
    BECKSTEAD, JH
    PRUSINER, SB
    [J]. NEUROLOGY, 1987, 37 (08) : 1271 - 1280
  • [10] THE NEUROCHEMISTRY OF PRION DISEASES
    DEARMOND, SJ
    PRUSINER, SB
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (05) : 1589 - 1601